ASEAN & Korea Interventional Oncology Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2017 to 2021 and Forecast 2022 to 2028

$ PRICE - $ 3,000.00$ 8,900.00

ASEAN & Korea Interventional Oncology Market: By Product (Radio embolic Agents, Non-Radio embolic Agents, Ablation Devices, Support Devices), By Cancer Type (Lung cancer, Breast cancer, Prostate cancer, Cervical cancer, Colorectal cancer, Acute Myeloid Leukemia, Others), By Procedure (Thermal Tumor Ablation, Non-Thermal Tumor Ablation, Transcatheter Arterial Chemoembolization, Transcatheter Arterial Radioembolization/Selective Internal Radiation Therapy, Transcatheter Arterial Embolization/Bland Embolization), Distribution Channel (Hospital Pharmacy, Ambulatory Surgery Centers, Research & Academic Institutes), and Geography

$ PRICE - $ 3,000.00$ 8,900.00
Clear selection
Clear
$ PRICE - $ 3,000.00$ 8,900.00
FacebookTwitterLinkedinEmail
SKU: N/A Category:

Report

Description

1 Executive Summary
2.ASEAN & Korea Interventional Oncology Market Introduction
2.1. ASEAN & Korea Interventional Oncology Market – Taxonomy
2.2. ASEAN & Korea Interventional Oncology Market –Definitions
2.2.1. By Product
2.2.2. By Cancer Type
2.2.3. By Procedure
2.2.4. By Distribution Channel
2.2.5. By Country
3. ASEAN & Korea Interventional Oncology Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. ASEAN & Korea Interventional Oncology Market Dynamic Factors – Impact Analysis
3.6. Impact of COVID-19 on The Market
3.7. Three Forecast Scenarios – Pessimistic, Conservative, and Opportunistic
3.8. Mapping Market Players’ Activities
3.9. Recent Key Developments
3.10. Financial Status of the Market Players
3.11. Recent Acquisitions, Collaborations, and Mergers
4.  ASEAN & Korea Interventional Oncology Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028
4.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Opportunity Analysis
5.  ASEAN & Korea Interventional Oncology Market Forecast, By Product, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
5.1. Radioembolic Agents
5.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.3. Market Opportunity Analysis
5.2. Non-Radio embolic Agents
5.2.1. Microspheres
5.2.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
5.2.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.1.3. Market Opportunity Analysis
5.2.2. Coated Beads
5.2.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
5.2.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.2.3. Market Opportunity Analysis
5.2.3. Microparticles
5.2.3.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
5.2.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.3.3. Market Opportunity Analysis
5.3. Ablation Devices
5.3.1. Radiofrequency (RF) Ablation Devices
5.3.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
5.3.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.3.1.3. Market Opportunity Analysis
5.3.2. Microwave Ablation Devices
5.3.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
5.3.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.3.2.3. Market Opportunity Analysis
5.3.3. Cryoablation Devices
5.3.3.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
5.3.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.3.3.3. Market Opportunity Analysis
5.3.4. Other Ablation Devices
5.3.4.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
5.3.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.3.4.3. Market Opportunity Analysis
5.4. Support Devices
5.4.1. Microcatheters
5.4.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
5.4.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.4.1.3. Market Opportunity Analysis
5.4.2. Guidewires
5.4.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
5.4.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.4.2.3. Market Opportunity Analysis
6. ASEAN & Korea Interventional Oncology Market Forecast, By Cancer Type, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
6.1. Lung cancer
6.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.1.3. Market Opportunity Analysis
6.2. Breast cancer
6.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.2.3. Market Opportunity Analysis
6.3. Prostate cancer
6.3.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.3.3. Market Opportunity Analysis
6.4. Cervical cancer
6.4.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
6.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.4.3. Market Opportunity Analysis
6.5. Colorectal cancer
6.5.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
6.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.5.3. Market Opportunity Analysis
6.6. Acute Myeloid Leukemia
6.6.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
6.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.6.3. Market Opportunity Analysis
6.7. Others
6.7.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
6.7.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.7.3. Market Opportunity Analysis
7. ASEAN & Korea Interventional Oncology Market Forecast, By Procedure, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
7.1. Thermal Tumor Ablation
7.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.1.3. Market Opportunity Analysis
7.2. Non-Thermal Tumor Ablation
7.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.2.3. Market Opportunity Analysis
7.3. Transcatheter Arterial Chemoembolization
7.3.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.3.3. Market Opportunity Analysis
7.4. Transcatheter Arterial Radioembolization/Selective Internal Radiation Therapy
7.4.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.4.3. Market Opportunity Analysis
7.5. Transcatheter Arterial Embolization/Bland Embolization
7.5.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
7.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.5.3. Market Opportunity Analysis
8. ASEAN & Korea Interventional Oncology Market Forecast, By Distribution Channel, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
8.1. Hospital Pharmacy
8.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.1.3. Market Opportunity Analysis
8.2. Ambulatory Surgery Centers
8.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.2.3. Market Opportunity Analysis
8.3. Research & Academic Institutes
8.3.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.3.3. Market Opportunity Analysis
9. ASEAN & Korea Interventional Oncology Market Forecast, By Country, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
9.1. Indonesia
9.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
9.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.1.3. Market Opportunity Analysis
9.2. Malaysia
9.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
9.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.2.3. Market Opportunity Analysis
9.3. Singapore
9.3.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
9.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.3.3. Market Opportunity Analysis
9.4. The Philippines
9.4.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
9.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.4.3. Market Opportunity Analysis
9.5. Vietnam
9.5.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
9.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.5.3. Market Opportunity Analysis
9.6. Thailand
9.6.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
9.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.6.3. Market Opportunity Analysis
9.7. Korea
9.7.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
9.7.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.7.3. Market Opportunity Analysis
9.8. ASEAN & Korea Interventional Oncology Market – Opportunity Analysis Index, By Product, By Procedure, By Cancer Type, By Distribution Channel, and Country, 2022 – 2028
10.Indonesia Interventional Oncology Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
10.1. By Product Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Million), Y-o-Y Growth (%), and Market Share (%)
10.1.1. Radioembolic Agents
10.1.2. Non-Radio embolic Agents
10.1.2.1. Microspheres
10.1.2.2. Coated Beads
10.1.2.3. Microparticles
10.1.3. Ablation Devices
10.1.3.1. Radiofrequency (RF) Ablation Devices
10.1.3.2. Microwave Ablation Devices
10.1.3.3. Cryoablation Devices
10.1.3.4. Other Ablation Devices
10.1.4. Support Devices
10.1.4.1. Microcatheters
10.1.4.2. Guidewires
10.2. By Cancer Type Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Million), Y-o-Y Growth (%), and Market Share (%)
10.2.1. Lung cancer
10.2.2. Breast cancer
10.2.3. Prostate cancer
10.2.4. Cervical cancer
10.2.5. Colorectal cancer
10.2.6. Acute Myeloid Leukemia
10.2.7. Others
10.3. By Procedure Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Million), Y-o-Y Growth (%), and Market Share (%)
10.3.1. Thermal Tumor Ablation
10.3.2. Non-Thermal Tumor Ablation
10.3.3. Transcatheter Arterial Chemoembolization
10.3.4. Transcatheter Arterial Radioembolization/Selective Internal Radiation Therapy
10.3.5. Transcatheter Arterial Embolization/Bland Embolization
10.4. By Distribution Channel Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Million), Y-o-Y Growth (%), and Market Share (%)
10.4.1. Hospital Pharmacy
10.4.2. Ambulatory Surgery Centers
10.4.3. Research & Academic Institutes
10.5. Indonesia Interventional Oncology Market – Opportunity Analysis Index, By Product, By Procedure, By Cancer Type, and By Distribution Channel, 2022 – 2028
10.6. Indonesia Interventional Oncology Market Dynamics – Trends
11 Malaysia Interventional Oncology Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
11.1. By Product Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Million), Y-o-Y Growth (%), and Market Share (%)
11.1.1. Radioembolic Agents
11.1.2. Non-Radio embolic Agents
11.1.2.1. Microspheres
11.1.2.2. Coated Beads
11.1.2.3. Microparticles
11.1.3. Ablation Devices
11.1.3.1. Radiofrequency (RF) Ablation Devices
11.1.3.2. Microwave Ablation Devices
11.1.3.3. Cryoablation Devices
11.1.3.4. Other Ablation Devices
11.1.4. Support Devices
11.1.4.1. Microcatheters
11.1.4.2. Guidewires
11.2. By Cancer Type Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Million), Y-o-Y Growth (%), and Market Share (%)
11.2.1. Lung cancer
11.2.2. Breast cancer
11.2.3. Prostate cancer
11.2.4. Cervical cancer
11.2.5. Colorectal cancer
11.2.6. Acute Myeloid Leukemia
11.2.7. Others
11.3. By Procedure Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Million), Y-o-Y Growth (%), and Market Share (%)
11.3.1. Thermal Tumor Ablation
11.3.2. Non-Thermal Tumor Ablation
11.3.3. Transcatheter Arterial Chemoembolization
11.3.4. Transcatheter Arterial Radioembolization/Selective Internal Radiation Therapy
11.3.5. Transcatheter Arterial Embolization/Bland Embolization
11.4. By Distribution Channel Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Million), Y-o-Y Growth (%), and Market Share (%)
11.4.1. Hospital Pharmacy
11.4.2. Ambulatory Surgery Centers
11.4.3. Research & Academic Institutes
11.5. Malaysia Interventional Oncology Market – Opportunity Analysis Index, By Product, By Procedure, By Cancer Type, and By Distribution Channel, 2022 – 2028
11.6. Malaysia Interventional Oncology Market Dynamics – Trends
12.  Singapore Interventional Oncology Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
12.1. By Product Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Million), Y-o-Y Growth (%), and Market Share (%)
12.1.1. Radioembolic Agents
12.1.2. Non-Radio embolic Agents
12.1.2.1. Microspheres
12.1.2.2. Coated Beads
12.1.2.3. Microparticles
12.1.3. Ablation Devices
12.1.3.1. Radiofrequency (RF) Ablation Devices
12.1.3.2. Microwave Ablation Devices
12.1.3.3. Cryoablation Devices
12.1.3.4. Other Ablation Devices
12.1.4. Support Devices
12.1.4.1. Microcatheters
12.1.4.2. Guidewires
12.2. By Cancer Type Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Million), Y-o-Y Growth (%), and Market Share (%)
12.2.1. Lung cancer
12.2.2. Breast cancer
12.2.3. Prostate cancer
12.2.4. Cervical cancer
12.2.5. Colorectal cancer
12.2.6. Acute Myeloid Leukemia
12.2.7. Others
12.3. By Procedure Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Million), Y-o-Y Growth (%), and Market Share (%)
12.3.1. Thermal Tumor Ablation
12.3.2. Non-Thermal Tumor Ablation
12.3.3. Transcatheter Arterial Chemoembolization
12.3.4. Transcatheter Arterial Radioembolization/Selective Internal Radiation Therapy
12.3.5. Transcatheter Arterial Embolization/Bland Embolization
12.4. By Distribution Channel Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Million), Y-o-Y Growth (%), and Market Share (%)
12.4.1. Hospital Pharmacy
12.4.2. Ambulatory Surgery Centers
12.4.3. Research & Academic Institutes
12.5. Singapore Interventional Oncology Market – Opportunity Analysis Index, By Product, By Procedure, By Cancer Type, and By Distribution Channel, 2022 – 2028
12.6. Singapore Interventional Oncology Market Dynamics – Trends
13.The Philippines Interventional Oncology Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
13.1. By Product Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Million), Y-o-Y Growth (%), and Market Share (%)
13.1.1. Radioembolic Agents
13.1.2. Non-Radio embolic Agents
13.1.2.1. Microspheres
13.1.2.2. Coated Beads
13.1.2.3. Microparticles
13.1.3. Ablation Devices
13.1.3.1. Radiofrequency (RF) Ablation Devices
13.1.3.2. Microwave Ablation Devices
13.1.3.3. Cryoablation Devices
13.1.3.4. Other Ablation Devices
13.1.4. Support Devices
13.1.4.1. Microcatheters
13.1.4.2. Guidewires
13.2. By Cancer Type Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Million), Y-o-Y Growth (%), and Market Share (%)
13.2.1. Lung cancer
13.2.2. Breast cancer
13.2.3. Prostate cancer
13.2.4. Cervical cancer
13.2.5. Colorectal cancer
13.2.6. Acute Myeloid Leukemia
13.2.7. Others
13.3. By Procedure Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Million), Y-o-Y Growth (%), and Market Share (%)
13.3.1. Thermal Tumor Ablation
13.3.2. Non-Thermal Tumor Ablation
13.3.3. Transcatheter Arterial Chemoembolization
13.3.4. Transcatheter Arterial Radioembolization/Selective Internal Radiation Therapy
13.3.5. Transcatheter Arterial Embolization/Bland Embolization
13.4. By Distribution Channel Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Million), Y-o-Y Growth (%), and Market Share (%)
13.4.1. Hospital Pharmacy
13.4.2. Ambulatory Surgery Centers
13.4.3. Research & Academic Institutes
13.5. The Philippines Interventional Oncology Market – Opportunity Analysis Index, By Product, By Procedure, By Cancer Type, and By Distribution Channel, 2022 – 2028
13.6. The Philippines Interventional Oncology Market Dynamics – Trends
14.  Vietnam Interventional Oncology Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
14.1. By Product Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Million), Y-o-Y Growth (%), and Market Share (%)
14.1.1. Radioembolic Agents
14.1.2. Non-Radio embolic Agents
14.1.2.1. Microspheres
14.1.2.2. Coated Beads
14.1.2.3. Microparticles
14.1.3. Ablation Devices
14.1.3.1. Radiofrequency (RF) Ablation Devices
14.1.3.2. Microwave Ablation Devices
14.1.3.3. Cryoablation Devices
14.1.3.4. Other Ablation Devices
14.1.4. Support Devices
14.1.4.1. Microcatheters
14.1.4.2. Guidewires
14.2. By Cancer Type Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Million), Y-o-Y Growth (%), and Market Share (%)
14.2.1. Lung cancer
14.2.2. Breast cancer
14.2.3. Prostate cancer
14.2.4. Cervical cancer
14.2.5. Colorectal cancer
14.2.6. Acute Myeloid Leukemia
14.2.7. Others
14.3. By Procedure Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Million), Y-o-Y Growth (%), and Market Share (%)
14.3.1. Thermal Tumor Ablation
14.3.2. Non-Thermal Tumor Ablation
14.3.3. Transcatheter Arterial Chemoembolization
14.3.4. Transcatheter Arterial Radioembolization/Selective Internal Radiation Therapy
14.3.5. Transcatheter Arterial Embolization/Bland Embolization
14.4. By Distribution Channel Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Million), Y-o-Y Growth (%), and Market Share (%)
14.4.1. Hospital Pharmacy
14.4.2. Ambulatory Surgery Centers
14.4.3. Research & Academic Institutes
14.5. Vietnam Interventional Oncology Market – Opportunity Analysis Index, By Product, By Procedure, By Cancer Type, and By Distribution Channel, 2022 – 2028
14.6. Vietnam Interventional Oncology Market Dynamics – Trends
15.  Thailand Interventional Oncology Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
15.1. By Product Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Million), Y-o-Y Growth (%), and Market Share (%)
15.1.1. Radioembolic Agents
15.1.2. Non-Radio embolic Agents
15.1.2.1. Microspheres
15.1.2.2. Coated Beads
15.1.2.3. Microparticles
15.1.3. Ablation Devices
15.1.3.1. Radiofrequency (RF) Ablation Devices
15.1.3.2. Microwave Ablation Devices
15.1.3.3. Cryoablation Devices
15.1.3.4. Other Ablation Devices
15.1.4. Support Devices
15.1.4.1. Microcatheters
15.1.4.2. Guidewires
15.2. By Cancer Type Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Million), Y-o-Y Growth (%), and Market Share (%)
15.2.1. Lung cancer
15.2.2. Breast cancer
15.2.3. Prostate cancer
15.2.4. Cervical cancer
15.2.5. Colorectal cancer
15.2.6. Acute Myeloid Leukemia
15.2.7. Others
15.3. By Procedure Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Million), Y-o-Y Growth (%), and Market Share (%)
15.3.1. Thermal Tumor Ablation
15.3.2. Non-Thermal Tumor Ablation
15.3.3. Transcatheter Arterial Chemoembolization
15.3.4. Transcatheter Arterial Radioembolization/Selective Internal Radiation Therapy
15.3.5. Transcatheter Arterial Embolization/Bland Embolization
15.4. By Distribution Channel Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Million), Y-o-Y Growth (%), and Market Share (%)
15.4.1. Hospital Pharmacy
15.4.2. Ambulatory Surgery Centers
15.4.3. Research & Academic Institutes
15.5. Thailand Interventional Oncology Market – Opportunity Analysis Index, By Product, By Procedure, By Cancer Type, and By Distribution Channel, 2022 – 2028
15.6. Thailand Interventional Oncology Market Dynamics – Trends
16.  Korea Interventional Oncology Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
16.1. By Product Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Million), Y-o-Y Growth (%), and Market Share (%)
16.1.1. Radioembolic Agents
16.1.2. Non-Radio embolic Agents
16.1.2.1. Microspheres
16.1.2.2. Coated Beads
16.1.2.3. Microparticles
16.1.3. Ablation Devices
16.1.3.1. Radiofrequency (RF) Ablation Devices
16.1.3.2. Microwave Ablation Devices
16.1.3.3. Cryoablation Devices
16.1.3.4. Other Ablation Devices
16.1.4. Support Devices
16.1.4.1. Microcatheters
16.1.4.2. Guidewires
16.2. By Cancer Type Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Million), Y-o-Y Growth (%), and Market Share (%)
16.2.1. Lung cancer
16.2.2. Breast cancer
16.2.3. Prostate cancer
16.2.4. Cervical cancer
16.2.5. Colorectal cancer
16.2.6. Acute Myeloid Leukemia
16.2.7. Others
16.3. By Procedure Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Million), Y-o-Y Growth (%), and Market Share (%)
16.3.1. Thermal Tumor Ablation
16.3.2. Non-Thermal Tumor Ablation
16.3.3. Transcatheter Arterial Chemoembolization
16.3.4. Transcatheter Arterial Radioembolization/Selective Internal Radiation Therapy
16.3.5. Transcatheter Arterial Embolization/Bland Embolization
16.4. By Distribution Channel Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Million), Y-o-Y Growth (%), and Market Share (%)
16.4.1. Hospital Pharmacy
16.4.2. Ambulatory Surgery Centers
16.4.3. Research & Academic Institutes
16.5. Korea Interventional Oncology Market – Opportunity Analysis Index, By Product, By Procedure, By Cancer Type, and By Distribution Channel, 2022 – 2028
16.6. Korea Interventional Oncology Market Dynamics – Trends
17.  Competition Landscape 
17.1. Strategic Dashboard of Top Market Players
17.2. Company Profiles (Introduction, Financial Analysis, By Product Offerings, Key Developments, Strategies, and SWOT Analysis)
17.2.1. Medtronic
17.2.2. Boston Scientific
17.2.3. Terumo
17.2.4. Merit Medical
17.2.5. AngioDynamics
17.2.6. J&J
17.2.7. Teleflex
17.2.8. Cook Medical
17.2.9. HealthTronics
17.2.10. MedWaves
17.2.11. Sanarus
17.2.12. IMBiotechnologies
17.2.13. Trod Medical
17.2.14. IceCure Medical
17.2.15. Mermaid Medicals
17.2.16. Interface Biomaterials BV
17.2.17. Guerbet
17.2.18. ABK Biomedical
17.2.19. Shape Memory Medical
17.2.20. Endo Shape
17.2.21. Monteris Medical
17.2.22. Instylla
17.2.23. Trisalus Lifesciences
17.2.24. Profound Medical Corp
17.2.25. SirtexAccuray
17.2.26. Baylis Medical
17.2.27. ALPINION MEDICAL SYSTEMS
18.  Research Methodology
19.  Key Assumptions and Acronyms

Frequently Asked Questions

2021 is the base year and 2028 is the forecast year.

In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.


Report

Company Profile

  • Medtronic
  •  Boston Scientific
  • Terumo
  •  Merit Medical
  •  AngioDynamics
  •  J&J
  •  Teleflex
  •  Cook Medical
  • HealthTronics
  •  MedWaves
  •  Sanarus
  •  IMBiotechnologies
  • Trod Medical
  • IceCure Medical
  • Mermaid Medicals
  • Interface Biomaterials BV
  • Guerbet
  • ABK Biomedical
  • Shape Memory Medical
  • Endo Shape
  • Monteris Medical
  • Instylla
  • Trisalus Lifesciences
  • Profound Medical Corp
  • SirtexAccuray
  • Baylis Medical
  • ALPINION MEDICAL SYSTEMS

Description

1 Executive Summary
2.ASEAN & Korea Interventional Oncology Market Introduction
2.1. ASEAN & Korea Interventional Oncology Market – Taxonomy
2.2. ASEAN & Korea Interventional Oncology Market –Definitions
2.2.1. By Product
2.2.2. By Cancer Type
2.2.3. By Procedure
2.2.4. By Distribution Channel
2.2.5. By Country
3. ASEAN & Korea Interventional Oncology Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. ASEAN & Korea Interventional Oncology Market Dynamic Factors – Impact Analysis
3.6. Impact of COVID-19 on The Market
3.7. Three Forecast Scenarios – Pessimistic, Conservative, and Opportunistic
3.8. Mapping Market Players’ Activities
3.9. Recent Key Developments
3.10. Financial Status of the Market Players
3.11. Recent Acquisitions, Collaborations, and Mergers
4.  ASEAN & Korea Interventional Oncology Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028
4.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Opportunity Analysis
5.  ASEAN & Korea Interventional Oncology Market Forecast, By Product, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
5.1. Radioembolic Agents
5.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.3. Market Opportunity Analysis
5.2. Non-Radio embolic Agents
5.2.1. Microspheres
5.2.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
5.2.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.1.3. Market Opportunity Analysis
5.2.2. Coated Beads
5.2.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
5.2.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.2.3. Market Opportunity Analysis
5.2.3. Microparticles
5.2.3.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
5.2.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.3.3. Market Opportunity Analysis
5.3. Ablation Devices
5.3.1. Radiofrequency (RF) Ablation Devices
5.3.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
5.3.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.3.1.3. Market Opportunity Analysis
5.3.2. Microwave Ablation Devices
5.3.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
5.3.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.3.2.3. Market Opportunity Analysis
5.3.3. Cryoablation Devices
5.3.3.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
5.3.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.3.3.3. Market Opportunity Analysis
5.3.4. Other Ablation Devices
5.3.4.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
5.3.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.3.4.3. Market Opportunity Analysis
5.4. Support Devices
5.4.1. Microcatheters
5.4.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
5.4.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.4.1.3. Market Opportunity Analysis
5.4.2. Guidewires
5.4.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
5.4.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.4.2.3. Market Opportunity Analysis
6. ASEAN & Korea Interventional Oncology Market Forecast, By Cancer Type, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
6.1. Lung cancer
6.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.1.3. Market Opportunity Analysis
6.2. Breast cancer
6.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.2.3. Market Opportunity Analysis
6.3. Prostate cancer
6.3.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.3.3. Market Opportunity Analysis
6.4. Cervical cancer
6.4.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
6.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.4.3. Market Opportunity Analysis
6.5. Colorectal cancer
6.5.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
6.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.5.3. Market Opportunity Analysis
6.6. Acute Myeloid Leukemia
6.6.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
6.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.6.3. Market Opportunity Analysis
6.7. Others
6.7.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
6.7.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.7.3. Market Opportunity Analysis
7. ASEAN & Korea Interventional Oncology Market Forecast, By Procedure, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
7.1. Thermal Tumor Ablation
7.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.1.3. Market Opportunity Analysis
7.2. Non-Thermal Tumor Ablation
7.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.2.3. Market Opportunity Analysis
7.3. Transcatheter Arterial Chemoembolization
7.3.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.3.3. Market Opportunity Analysis
7.4. Transcatheter Arterial Radioembolization/Selective Internal Radiation Therapy
7.4.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.4.3. Market Opportunity Analysis
7.5. Transcatheter Arterial Embolization/Bland Embolization
7.5.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
7.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.5.3. Market Opportunity Analysis
8. ASEAN & Korea Interventional Oncology Market Forecast, By Distribution Channel, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
8.1. Hospital Pharmacy
8.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.1.3. Market Opportunity Analysis
8.2. Ambulatory Surgery Centers
8.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.2.3. Market Opportunity Analysis
8.3. Research & Academic Institutes
8.3.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.3.3. Market Opportunity Analysis
9. ASEAN & Korea Interventional Oncology Market Forecast, By Country, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
9.1. Indonesia
9.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
9.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.1.3. Market Opportunity Analysis
9.2. Malaysia
9.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
9.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.2.3. Market Opportunity Analysis
9.3. Singapore
9.3.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
9.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.3.3. Market Opportunity Analysis
9.4. The Philippines
9.4.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
9.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.4.3. Market Opportunity Analysis
9.5. Vietnam
9.5.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
9.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.5.3. Market Opportunity Analysis
9.6. Thailand
9.6.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
9.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.6.3. Market Opportunity Analysis
9.7. Korea
9.7.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
9.7.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.7.3. Market Opportunity Analysis
9.8. ASEAN & Korea Interventional Oncology Market – Opportunity Analysis Index, By Product, By Procedure, By Cancer Type, By Distribution Channel, and Country, 2022 – 2028
10.Indonesia Interventional Oncology Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
10.1. By Product Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Million), Y-o-Y Growth (%), and Market Share (%)
10.1.1. Radioembolic Agents
10.1.2. Non-Radio embolic Agents
10.1.2.1. Microspheres
10.1.2.2. Coated Beads
10.1.2.3. Microparticles
10.1.3. Ablation Devices
10.1.3.1. Radiofrequency (RF) Ablation Devices
10.1.3.2. Microwave Ablation Devices
10.1.3.3. Cryoablation Devices
10.1.3.4. Other Ablation Devices
10.1.4. Support Devices
10.1.4.1. Microcatheters
10.1.4.2. Guidewires
10.2. By Cancer Type Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Million), Y-o-Y Growth (%), and Market Share (%)
10.2.1. Lung cancer
10.2.2. Breast cancer
10.2.3. Prostate cancer
10.2.4. Cervical cancer
10.2.5. Colorectal cancer
10.2.6. Acute Myeloid Leukemia
10.2.7. Others
10.3. By Procedure Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Million), Y-o-Y Growth (%), and Market Share (%)
10.3.1. Thermal Tumor Ablation
10.3.2. Non-Thermal Tumor Ablation
10.3.3. Transcatheter Arterial Chemoembolization
10.3.4. Transcatheter Arterial Radioembolization/Selective Internal Radiation Therapy
10.3.5. Transcatheter Arterial Embolization/Bland Embolization
10.4. By Distribution Channel Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Million), Y-o-Y Growth (%), and Market Share (%)
10.4.1. Hospital Pharmacy
10.4.2. Ambulatory Surgery Centers
10.4.3. Research & Academic Institutes
10.5. Indonesia Interventional Oncology Market – Opportunity Analysis Index, By Product, By Procedure, By Cancer Type, and By Distribution Channel, 2022 – 2028
10.6. Indonesia Interventional Oncology Market Dynamics – Trends
11 Malaysia Interventional Oncology Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
11.1. By Product Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Million), Y-o-Y Growth (%), and Market Share (%)
11.1.1. Radioembolic Agents
11.1.2. Non-Radio embolic Agents
11.1.2.1. Microspheres
11.1.2.2. Coated Beads
11.1.2.3. Microparticles
11.1.3. Ablation Devices
11.1.3.1. Radiofrequency (RF) Ablation Devices
11.1.3.2. Microwave Ablation Devices
11.1.3.3. Cryoablation Devices
11.1.3.4. Other Ablation Devices
11.1.4. Support Devices
11.1.4.1. Microcatheters
11.1.4.2. Guidewires
11.2. By Cancer Type Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Million), Y-o-Y Growth (%), and Market Share (%)
11.2.1. Lung cancer
11.2.2. Breast cancer
11.2.3. Prostate cancer
11.2.4. Cervical cancer
11.2.5. Colorectal cancer
11.2.6. Acute Myeloid Leukemia
11.2.7. Others
11.3. By Procedure Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Million), Y-o-Y Growth (%), and Market Share (%)
11.3.1. Thermal Tumor Ablation
11.3.2. Non-Thermal Tumor Ablation
11.3.3. Transcatheter Arterial Chemoembolization
11.3.4. Transcatheter Arterial Radioembolization/Selective Internal Radiation Therapy
11.3.5. Transcatheter Arterial Embolization/Bland Embolization
11.4. By Distribution Channel Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Million), Y-o-Y Growth (%), and Market Share (%)
11.4.1. Hospital Pharmacy
11.4.2. Ambulatory Surgery Centers
11.4.3. Research & Academic Institutes
11.5. Malaysia Interventional Oncology Market – Opportunity Analysis Index, By Product, By Procedure, By Cancer Type, and By Distribution Channel, 2022 – 2028
11.6. Malaysia Interventional Oncology Market Dynamics – Trends
12.  Singapore Interventional Oncology Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
12.1. By Product Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Million), Y-o-Y Growth (%), and Market Share (%)
12.1.1. Radioembolic Agents
12.1.2. Non-Radio embolic Agents
12.1.2.1. Microspheres
12.1.2.2. Coated Beads
12.1.2.3. Microparticles
12.1.3. Ablation Devices
12.1.3.1. Radiofrequency (RF) Ablation Devices
12.1.3.2. Microwave Ablation Devices
12.1.3.3. Cryoablation Devices
12.1.3.4. Other Ablation Devices
12.1.4. Support Devices
12.1.4.1. Microcatheters
12.1.4.2. Guidewires
12.2. By Cancer Type Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Million), Y-o-Y Growth (%), and Market Share (%)
12.2.1. Lung cancer
12.2.2. Breast cancer
12.2.3. Prostate cancer
12.2.4. Cervical cancer
12.2.5. Colorectal cancer
12.2.6. Acute Myeloid Leukemia
12.2.7. Others
12.3. By Procedure Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Million), Y-o-Y Growth (%), and Market Share (%)
12.3.1. Thermal Tumor Ablation
12.3.2. Non-Thermal Tumor Ablation
12.3.3. Transcatheter Arterial Chemoembolization
12.3.4. Transcatheter Arterial Radioembolization/Selective Internal Radiation Therapy
12.3.5. Transcatheter Arterial Embolization/Bland Embolization
12.4. By Distribution Channel Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Million), Y-o-Y Growth (%), and Market Share (%)
12.4.1. Hospital Pharmacy
12.4.2. Ambulatory Surgery Centers
12.4.3. Research & Academic Institutes
12.5. Singapore Interventional Oncology Market – Opportunity Analysis Index, By Product, By Procedure, By Cancer Type, and By Distribution Channel, 2022 – 2028
12.6. Singapore Interventional Oncology Market Dynamics – Trends
13.The Philippines Interventional Oncology Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
13.1. By Product Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Million), Y-o-Y Growth (%), and Market Share (%)
13.1.1. Radioembolic Agents
13.1.2. Non-Radio embolic Agents
13.1.2.1. Microspheres
13.1.2.2. Coated Beads
13.1.2.3. Microparticles
13.1.3. Ablation Devices
13.1.3.1. Radiofrequency (RF) Ablation Devices
13.1.3.2. Microwave Ablation Devices
13.1.3.3. Cryoablation Devices
13.1.3.4. Other Ablation Devices
13.1.4. Support Devices
13.1.4.1. Microcatheters
13.1.4.2. Guidewires
13.2. By Cancer Type Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Million), Y-o-Y Growth (%), and Market Share (%)
13.2.1. Lung cancer
13.2.2. Breast cancer
13.2.3. Prostate cancer
13.2.4. Cervical cancer
13.2.5. Colorectal cancer
13.2.6. Acute Myeloid Leukemia
13.2.7. Others
13.3. By Procedure Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Million), Y-o-Y Growth (%), and Market Share (%)
13.3.1. Thermal Tumor Ablation
13.3.2. Non-Thermal Tumor Ablation
13.3.3. Transcatheter Arterial Chemoembolization
13.3.4. Transcatheter Arterial Radioembolization/Selective Internal Radiation Therapy
13.3.5. Transcatheter Arterial Embolization/Bland Embolization
13.4. By Distribution Channel Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Million), Y-o-Y Growth (%), and Market Share (%)
13.4.1. Hospital Pharmacy
13.4.2. Ambulatory Surgery Centers
13.4.3. Research & Academic Institutes
13.5. The Philippines Interventional Oncology Market – Opportunity Analysis Index, By Product, By Procedure, By Cancer Type, and By Distribution Channel, 2022 – 2028
13.6. The Philippines Interventional Oncology Market Dynamics – Trends
14.  Vietnam Interventional Oncology Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
14.1. By Product Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Million), Y-o-Y Growth (%), and Market Share (%)
14.1.1. Radioembolic Agents
14.1.2. Non-Radio embolic Agents
14.1.2.1. Microspheres
14.1.2.2. Coated Beads
14.1.2.3. Microparticles
14.1.3. Ablation Devices
14.1.3.1. Radiofrequency (RF) Ablation Devices
14.1.3.2. Microwave Ablation Devices
14.1.3.3. Cryoablation Devices
14.1.3.4. Other Ablation Devices
14.1.4. Support Devices
14.1.4.1. Microcatheters
14.1.4.2. Guidewires
14.2. By Cancer Type Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Million), Y-o-Y Growth (%), and Market Share (%)
14.2.1. Lung cancer
14.2.2. Breast cancer
14.2.3. Prostate cancer
14.2.4. Cervical cancer
14.2.5. Colorectal cancer
14.2.6. Acute Myeloid Leukemia
14.2.7. Others
14.3. By Procedure Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Million), Y-o-Y Growth (%), and Market Share (%)
14.3.1. Thermal Tumor Ablation
14.3.2. Non-Thermal Tumor Ablation
14.3.3. Transcatheter Arterial Chemoembolization
14.3.4. Transcatheter Arterial Radioembolization/Selective Internal Radiation Therapy
14.3.5. Transcatheter Arterial Embolization/Bland Embolization
14.4. By Distribution Channel Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Million), Y-o-Y Growth (%), and Market Share (%)
14.4.1. Hospital Pharmacy
14.4.2. Ambulatory Surgery Centers
14.4.3. Research & Academic Institutes
14.5. Vietnam Interventional Oncology Market – Opportunity Analysis Index, By Product, By Procedure, By Cancer Type, and By Distribution Channel, 2022 – 2028
14.6. Vietnam Interventional Oncology Market Dynamics – Trends
15.  Thailand Interventional Oncology Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
15.1. By Product Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Million), Y-o-Y Growth (%), and Market Share (%)
15.1.1. Radioembolic Agents
15.1.2. Non-Radio embolic Agents
15.1.2.1. Microspheres
15.1.2.2. Coated Beads
15.1.2.3. Microparticles
15.1.3. Ablation Devices
15.1.3.1. Radiofrequency (RF) Ablation Devices
15.1.3.2. Microwave Ablation Devices
15.1.3.3. Cryoablation Devices
15.1.3.4. Other Ablation Devices
15.1.4. Support Devices
15.1.4.1. Microcatheters
15.1.4.2. Guidewires
15.2. By Cancer Type Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Million), Y-o-Y Growth (%), and Market Share (%)
15.2.1. Lung cancer
15.2.2. Breast cancer
15.2.3. Prostate cancer
15.2.4. Cervical cancer
15.2.5. Colorectal cancer
15.2.6. Acute Myeloid Leukemia
15.2.7. Others
15.3. By Procedure Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Million), Y-o-Y Growth (%), and Market Share (%)
15.3.1. Thermal Tumor Ablation
15.3.2. Non-Thermal Tumor Ablation
15.3.3. Transcatheter Arterial Chemoembolization
15.3.4. Transcatheter Arterial Radioembolization/Selective Internal Radiation Therapy
15.3.5. Transcatheter Arterial Embolization/Bland Embolization
15.4. By Distribution Channel Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Million), Y-o-Y Growth (%), and Market Share (%)
15.4.1. Hospital Pharmacy
15.4.2. Ambulatory Surgery Centers
15.4.3. Research & Academic Institutes
15.5. Thailand Interventional Oncology Market – Opportunity Analysis Index, By Product, By Procedure, By Cancer Type, and By Distribution Channel, 2022 – 2028
15.6. Thailand Interventional Oncology Market Dynamics – Trends
16.  Korea Interventional Oncology Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
16.1. By Product Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Million), Y-o-Y Growth (%), and Market Share (%)
16.1.1. Radioembolic Agents
16.1.2. Non-Radio embolic Agents
16.1.2.1. Microspheres
16.1.2.2. Coated Beads
16.1.2.3. Microparticles
16.1.3. Ablation Devices
16.1.3.1. Radiofrequency (RF) Ablation Devices
16.1.3.2. Microwave Ablation Devices
16.1.3.3. Cryoablation Devices
16.1.3.4. Other Ablation Devices
16.1.4. Support Devices
16.1.4.1. Microcatheters
16.1.4.2. Guidewires
16.2. By Cancer Type Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Million), Y-o-Y Growth (%), and Market Share (%)
16.2.1. Lung cancer
16.2.2. Breast cancer
16.2.3. Prostate cancer
16.2.4. Cervical cancer
16.2.5. Colorectal cancer
16.2.6. Acute Myeloid Leukemia
16.2.7. Others
16.3. By Procedure Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Million), Y-o-Y Growth (%), and Market Share (%)
16.3.1. Thermal Tumor Ablation
16.3.2. Non-Thermal Tumor Ablation
16.3.3. Transcatheter Arterial Chemoembolization
16.3.4. Transcatheter Arterial Radioembolization/Selective Internal Radiation Therapy
16.3.5. Transcatheter Arterial Embolization/Bland Embolization
16.4. By Distribution Channel Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Million), Y-o-Y Growth (%), and Market Share (%)
16.4.1. Hospital Pharmacy
16.4.2. Ambulatory Surgery Centers
16.4.3. Research & Academic Institutes
16.5. Korea Interventional Oncology Market – Opportunity Analysis Index, By Product, By Procedure, By Cancer Type, and By Distribution Channel, 2022 – 2028
16.6. Korea Interventional Oncology Market Dynamics – Trends
17.  Competition Landscape 
17.1. Strategic Dashboard of Top Market Players
17.2. Company Profiles (Introduction, Financial Analysis, By Product Offerings, Key Developments, Strategies, and SWOT Analysis)
17.2.1. Medtronic
17.2.2. Boston Scientific
17.2.3. Terumo
17.2.4. Merit Medical
17.2.5. AngioDynamics
17.2.6. J&J
17.2.7. Teleflex
17.2.8. Cook Medical
17.2.9. HealthTronics
17.2.10. MedWaves
17.2.11. Sanarus
17.2.12. IMBiotechnologies
17.2.13. Trod Medical
17.2.14. IceCure Medical
17.2.15. Mermaid Medicals
17.2.16. Interface Biomaterials BV
17.2.17. Guerbet
17.2.18. ABK Biomedical
17.2.19. Shape Memory Medical
17.2.20. Endo Shape
17.2.21. Monteris Medical
17.2.22. Instylla
17.2.23. Trisalus Lifesciences
17.2.24. Profound Medical Corp
17.2.25. SirtexAccuray
17.2.26. Baylis Medical
17.2.27. ALPINION MEDICAL SYSTEMS
18.  Research Methodology
19.  Key Assumptions and Acronyms

ASIA PACIFIC OFFICE

Precision Business Insights, MIG 366, SAI PLAZA, 1st Floor, KPHB Colony, Hyderabad - 500072

EUROPE OFFICE

Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX